The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

February 1997

Volume 37, Issue 2

Pages 83–173

  1. Pharmacoepidemiology

    1. Top of page
    2. Pharmacoepidemiology
    3. Cardiovascular Pharmacology
    4. Pharmacokinetics
    5. Therapeutics
    6. Drug Interactions
    7. Departments
    1. Acetylator Phenotype in Relation to Age and Gender in the Baltimore Longitudinal Study of Aging (pages 83–91)

      Dr. Madhu R. Korrapati, Dr. John D. Sorkin, Dr. Reubin Andres, Dr. Denis C. Muller, Dr. Cho-Ming Loi, Dr. Elliot S. Vesell and Dr. Robert E. Vestal

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04765.x

    2. Population-Based Investigation of Relative Clearance of Digoxin in Japanese Patients by Multiple Trough Screen Analysis: An Update (pages 92–100)

      Dr. Eiji Yukawa, Ms. Tomoo Honda, Dr. Shigehiro Ohdo, Dr. Shun Higuchi and Dr. Toshinobu Aoyama

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04766.x

  2. Cardiovascular Pharmacology

    1. Top of page
    2. Pharmacoepidemiology
    3. Cardiovascular Pharmacology
    4. Pharmacokinetics
    5. Therapeutics
    6. Drug Interactions
    7. Departments
    1. Valsartan, a New Angiotensin II Receptor Antagonist: A Double-Blind Study Comparing the Incidence of Cough with Lisinopril and Hydrochlorothiazide (pages 101–107)

      Dr. Joan Benz, Dr. Carl Oshrain, Dr. Dan Henry, Christine Avery, Dr. Yann-Tong Chiang and Dr. Marjorie Gatlin

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04767.x

    2. Pharmacokinetics and Effect of Ticlopidine on Platelet Aggregation in Subjects with Normal and Impaired Renal Function (pages 108–115)

      Dr. Tom Buur, Dr. Rutger Larsson, Dr. Ulf Berglund, Dr. Francois Donat and Dr. Claude Tronquet

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04768.x

    3. Pharmacokinetics and Cardiovascular Effects of Ma-Huang (Ephedra sinica) in Normotensive Adults (pages 116–122)

      Dr. Laura M. White, Dr. Stephanie F. Gardner, Dr. Bill J. Gurley, Dr. Michael A. Marx, Ms. Pei-Ling Wang and Dr. Mark Estes

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04769.x

  3. Pharmacokinetics

    1. Top of page
    2. Pharmacoepidemiology
    3. Cardiovascular Pharmacology
    4. Pharmacokinetics
    5. Therapeutics
    6. Drug Interactions
    7. Departments
    1. Initial Pharmacokinetics and Bioavailability of PSC 833, a P-Glycoprotein Antagonist (pages 123–128)

      Dr. Richard M. Lush, Ms. Beverly Meadows, Dr. Antonio T. Fojo, Dr. Gaetana Kalafsky, Dr. Harold T. Smith, Dr. Susan Bates and Dr. William D. Figg

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04770.x

    2. Effect of Acute Phase Response on Phenytoin Metabolism in Neurotrauma Patients (pages 129–139)

      Dr. David S. McKindley, Dr. Bradley A. Boucher, Dr. Mary M. Hess, Dr. John H. Rodman, Dr. Claudio Feler and Dr. Timothy C. Fabian

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04771.x

  4. Therapeutics

    1. Top of page
    2. Pharmacoepidemiology
    3. Cardiovascular Pharmacology
    4. Pharmacokinetics
    5. Therapeutics
    6. Drug Interactions
    7. Departments
    1. Administration of H1 and H2 Antagonists for Chemoprophylaxis: A Double-Blind, Placebo-Controlled Study in Healthy Volunteers (pages 140–146)

      Dr. Alfred Doenicke, Dr. Jonathan Moss, Dr. Alicia Toledano, Dr. Rainer Hoernecke, Dr. Wilfried Lorenz and Dr. Philipp Ostwald

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04772.x

    2. Effect of Patient and Family Insight on Compliance of Schizophrenic Patients (pages 147–154)

      Dr. Cedric M. Smith, Dr. Drew Barzman and Dr. Cynthia A. Pristach

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04773.x

  5. Drug Interactions

    1. Top of page
    2. Pharmacoepidemiology
    3. Cardiovascular Pharmacology
    4. Pharmacokinetics
    5. Therapeutics
    6. Drug Interactions
    7. Departments
    1. Eprosartan, an Angiotensin II Receptor Antagonist, Does Not Affect the Pharmacodynamics of Glyburide in Patients with Type II Diabetes Mellitus (pages 155–159)

      Dr. David E. Martin, Dr. G. Stephen DeCherney, Dr. Bernard E. Ilson, Dr. Beverly A. Jones, Dr. Steven C. Boike, Dr. Martin I. Freed and Dr. Diane K. Jorkasky

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04774.x

    2. Evaluation of Pharmacokinetic Interaction Between Bromfenac and Phenytoin in Healthy Males (pages 160–168)

      Dr. Kavita Gumbhir-Shah, Dr. William H. Cevallos, Ms. Sheryl A. DeCleene and Dr. Joan M. Korth-Bradley

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04775.x

  6. Departments

    1. Top of page
    2. Pharmacoepidemiology
    3. Cardiovascular Pharmacology
    4. Pharmacokinetics
    5. Therapeutics
    6. Drug Interactions
    7. Departments
    1. ACCP Announcements (page 170)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04776.x

    2. Abstract Submission Form (page 173)

      Version of Record online: 8 MAR 2013 | DOI: 10.1002/j.1552-4604.1997.tb04777.x

SEARCH

SEARCH BY CITATION